Aalto NeuroImaging is an open-access research infrastructure focusing on functional neuroimaging in healthy subjects. Their unique portfolio in Finland comprises MEG, functional magnetic resonance imaging, navigated transcranial magnetic stimulation, and behavioral lab. We discuss MEG and how it is utilized in a variety of projects and studies at what is becoming a Center of Excellence for Neuroimaging in Europe.

MEGIN’s guests are truly experts in installing and maintaining MEG Lab’s around the globe. In MEGIN’s 30 year history, over 120 devices have been delivered, and there are currently over 83 systems in operation in about 24 countries. We were keen to have members of the team on the Spotlight today, to find out more about the process of setting up a MEG lab and explain how our team offers their expertise to benefit our customers through a partnership, whether to support in the planning phase, to assist in optimal use of the device, or to resolve technical problems.

MEGIN is delighted to have Dr. Vladimir Litvak as a guest. He is the Senior Research Associate at the Wellcome Centre for Human Neuroimaging, at UCL’s Institute of Neurology. Dr. Litvak is responsible for developing EEG/MEG analysis methods. The Wellcome Centre for Human Neuroimaging at UCL focuses on the collection of methods that investigate human brain structure and function. As a Senior Researcher at the centre, Dr. Litvak is heavily involved in work concentrating on cortico-subcortical communication.

MEGIN is delighted to welcome strategic software partners, BESA GmbH. Dr. Tobias Scherg, CEO and Managing Director and Dr. Harald Bornfleth, Vice President, Research & Product Management as our guests, who gave us more insight into how BESA started in the EEG/MEG field more than 25 years ago.

Dr. Arjan Hillebrand is an Associate Professor at the Clinical Neurophysiology department at Amsterdam University Medical Centers. VUMC is rated as one of the best academic medical centers in the country in terms of patient care and research. Besides the established use of MEG in patients with epilepsy who are candidates for epilepsy surgery, MEG is also routinely utilized for differential diagnosis in patients who visit VUmc’s memory clinic. The entire brain coverage of the system has greatly enhanced the center’s capability to approach the brain as a complex network, which has provided fundamental insights into the disease mechanisms in several neurological disorders.

Dr. Arjan Hillebrand describes how has the Internal Helium Recycler (IHR) improved efficiency in Amsterdam University Medical Center’s routine. The IHR brings zero helium boil-off technology to MEGIN’s hardware. Find out more in this interview.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

MEGIN was delighted to welcome Re:Cognition Health’s Steve Allder, Brain and Mind Experts in the UK specializing in the diagnosis and treatment of a wide range of conditions, such as Autism, Alzheimer’s disease, Parkinson’s, and Traumatic Brain Injury utilizing MEG Technology during patient’s treatment plans. We discuss case studies in which MEG enabled patients to gain an insight into their current health situation and provide more clarity.

Lauri Parkkonen and Rasmus Zetter from MEGIN, Helsinki team discuss differences between OPM technology and conventional SQUID-based MEG. We discover the benefits of each technology and its utilization and application.

MEGIN invited Professor Nobukazu Nakasato, Chair of the Epileptology Department at Tohoku University, Japan. Professor Nakasato, describes in this talk how is Magnetoencephalography (MEG) is incorporated into the operational flow of the epileptology department, i.e. how is MEG used in conjunction with other modalities. In this interview, he also touches upon how a MEG scan might benefit the epilepsy care plan for patients.

*MEGIN Spotlights content and speakers selected are only for information purposes and MEGIN does not endorse any applications or treatments mentioned. This presentation does not constitute any form of medical opinion or professional advice.

MEGIN invited Dr. Olaf Hauk, the Senior Investigator Scientist at the MRC Cognition and Brain Sciences Unit at the University of Cambridge as a guest to give our viewers an insight into how Magnetoencephalography (MEG) is utilized at the Cognition and Brain Sciences Unit in a number of research studies using a multi-modal imaging approach to problems in the neuroscience of language and cognition.